CVI Holdings’s Intelligent Bio Solutions INBS Stock Holding History

CVI Holdings’s Portfolio INBS Stock Details INBS Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q2	$153K	Sell	7,984 -2,841	-26%	-$72.7K	0.13%	40
2024 Q1	$457K	Buy	+10,825	New	+$448K	0.43%	27

Other funds holding INBS

ACM

ADAR1 Capital Management Austin, Texas $2.19B AUM 374.99% 1-Year Est. Return

ACM

Altium Capital Management New York $47.5M AUM 115.72% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return

TRCT

Tower Research Capital (TRC) New York $4.08B AUM 58.77% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return

CVI Holdings's INBS Position: Q2 2024 in Review

CVI Holdings reduced its Intelligent Bio Solutions (INBS) stake by 26% in Q2 2024, selling an estimated $72.7K and leaving 7,984 shares worth $153K. The position accounts for 0.13% of the portfolio, ranked #40.

CVI Holdings first reported a position in INBS in Q1 2024 and has held it in 2 quarters since. The position peaked at $457K in Q1 2024. 8 funds tracked by Wall St. Rank hold INBS as of Q2 2024.

CVI Holdings held 7,984 shares of Intelligent Bio Solutions worth $153K as of Q2 2024.
CVI Holdings sold 2,841 Intelligent Bio Solutions shares in Q2 2024, an estimated $72.7K.
Intelligent Bio Solutions made up 0.13% of CVI Holdings's portfolio in Q2 2024, its #40 holding.
CVI Holdings first reported a position in Intelligent Bio Solutions in Q1 2024 and has held it in 2 quarters since.
CVI Holdings's Intelligent Bio Solutions position peaked at $457K in Q1 2024.
8 funds tracked by Wall St. Rank held Intelligent Bio Solutions as of Q2 2024.

Based on CVI Holdings's 13F filing for Q2 2024, filed 15 Aug 2024.